Yumanity Therapeutics, INC.
SEC CIK 1445283 · YMTX · last insider filing 2025-07-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Arkowitz David | Director | filed 2019 - 2025 |
| Drapkin Kimberlee C | Director | filed 2019 - 2025 |
| Foote Marion R | Director | filed 2022 - 2025 |
| Peters Richard | Director · President and CEO | filed 2020 - 2025 |
| Bartoszek Raymond J. | Director | filed 2022 - 2025 |
| Iadonato Shawn | Director · Chief Executive Officer | filed 2022 - 2025 |
| Dylla Scott J. | Director | filed 2023 - 2025 |
| Pickett Cecil B | Director | filed 2020 - 2021 |
| Allen Patricia L | Director | filed 2020 - 2021 |
| Heyman Richard A. | Director | filed 2020 - 2021 |
| Kelly Jeffrey W. | Director | filed 2016 - 2021 |
| Zydowsky Lynne | Director | filed 2020 - 2021 |
| Coles N Anthony | Director · Executive Chair | filed 2020 - 2021 |
| Berger Franklin M | Director | filed 2016 - 2020 |
| Dulac Emmanuel | Director | filed 2019 - 2020 |
| Chowdhury Badrul A. | Director | filed 2019 - 2020 |
| Chhabra Meenu | Director · President and CEO | filed 2016 - 2020 |
| Barrett M James | Director | filed 2016 - 2018 |
| Rabinowitz Eric | Director | filed 2016 - 2018 |
| Boudreau Helen M | Director · Chief Financial Officer | filed 2016 - 2018 |
| Chen Bihua | Director | filed 2016 - 2017 |
| Mirabelli Christopher | Director | filed 2016 - 2016 |
| Walsh Christopher T PHD | Director | filed 2016 - 2016 |
| Walshe Conor M | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Philips Craig W. | President and Secretary | filed 2022 - 2025 |
| Baker Keith | Chief Financial Officer | filed 2022 - 2025 |
| Guillaudeux Thierry | Chief Scientific Officer | filed 2022 - 2025 |
| Kenny Pauline | General Counsel & Secretary | filed 2022 - 2023 |
| Smith Devin Whittemore | SVP and General Counsel | filed 2021 - 2022 |
| Epstein Marie | Principal Accounting Officer | filed 2020 - 2022 |
| Wyzga Michael D | See Remarks | filed 2021 - 2022 |
| Mohsen Paulash | Chief Business Officer | filed 2020 - 2022 |
| Verma Ajay | EVP, Head of R&D | filed 2021 - 2021 |
| Robertson Brigitte | Chief Medical Officer | filed 2020 - 2021 |
| Alfieri Michael | Interim Head of Finance | filed 2020 - 2020 |
| Munoz Benito | See Remarks | filed 2016 - 2020 |
| Larson Eric D | See Remarks | filed 2019 - 2020 |
| Gilmartin Greffrey S. | See Remarks | filed 2016 - 2020 |
| Zecevic Marija | VP, Business Development | filed 2016 - 2020 |
| Wilson Sheila | Chief Operating Officer | filed 2019 - 2020 |
| Lee Po Shun | See Remarks | filed 2016 - 2019 |
| Zimmerman Sandra M. | See Remarks | filed 2018 - 2018 |
| Hagen Brett R | See Remarks | filed 2016 - 2017 |
| Detore James M. | See Remarks | filed 2016 - 2016 |
| Mirzac Romeo | Principal Accounting Officer | filed 2016 - 2016 |
| Smart Janet L | See Remarks | filed 2016 - 2016 |
| Thibault Lance E | See Remarks | filed 2016 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.